Uterine Fibroids News and Research

Latest Uterine Fibroids News and Research

Pandemic highlights need for urgent care clinics for women

Last spring, only weeks into the pandemic, Christina Garcia was spending her days struggling to help her two young sons adjust to online schooling when she got such a heavy, painful period she could barely stand. After a few days, her vision began to blur and she found herself too weak to open a jar.

16 Apr 2021

Study shows ultrasound treatment can destroy cancer cells without surgery

Focusing ultrasound energy on a target site in the body to generate heat can burn and destroy the tissue in the site without a surgical procedure.

27 Oct 2020

Researchers discover how CDK8 oncogene gets activated in healthy humans

Most cancers are caused by a large variety of factors that vary from one person to another. To unravel this complexity, genes that contribute to the development of a respective cancer must be identified. Such genes are called oncogenes. A good example of an oncogene is CDK8: Cyclin-dependent kinase 8.

28 Jan 2020

Elagolix drug suppresses ovarian hormone production, prevents heavy menstrual bleeding

About 50 % of women with uterine fibroids--non-cancerous muscle tumors that grow in the uterus--experience heavy menstrual bleeding and other symptoms. Surgery is commonly recommended when these symptoms are severe enough to prompt a woman to seek treatment.

23 Jan 2020

FDA orders surgical mesh manufacturers to stop selling and distributing their products in the U.S.

The U.S. Food and Drug Administration today ordered the manufacturers of all remaining surgical mesh products indicated for the transvaginal repair of pelvic organ prolapse (POP) to stop selling and distributing their products in the U.S. immediately.

17 Apr 2019

New proteomics-based test could aid in early detection of ovarian cancer

Fewer than half of ovarian cancer patients survive until five years after diagnosis. According to the American Cancer Society, this is because only about one-fifth of ovarian cancer cases are detected early, when the chances of successful treatment and recovery are highest.

15 Mar 2019

FDA warns Total Thermal Imaging for illegally marketing unapproved thermography device

The U.S. Food and Drug Administration has issued a warning letter toTotal Thermal Imaging Inc., of La Mesa, California, and its president and co-owner, Linda Hayes, for illegally marketing and distributing an unapproved thermography device as a sole screening device for breast cancer and other diseases.

25 Feb 2019

FDA warns doctor for illegally marketing unapproved implantable device

Today, the U.S. Food and Drug Administration issued a warning letter to Mark Berman, M.D., of Beverly Hills, California, for illegally marketing an unapproved implantable device, the Pocket Protector, that Dr. Berman claims can prevent and treat a complication of breast implants known as capsular contracture, or tightening of scar tissue.

14 Feb 2019

New oral drug reduces menstrual bleeding for women with common uterine tumors

A new oral drug significantly reduced menstrual bleeding for women with the most common gynecologic tumors in the United States - benign tumors that disproportionately affect African-Americans, an international clinical trial found.

9 Nov 2018

New study offers infertile women information on expected probabilities of becoming pregnant

A new Journal of Obstetrics and Gynaecology Research study offers infertile women new information regarding their expected probabilities of becoming pregnant and may help them select the optimal treatment based on their various risk factors.

3 Oct 2018

Cornwall and Chongqing Haifu partners to introduce HIFU tumor therapy system

Cornwall Medical Group enters a strategic partnership with the world's leading medical equipment and integrated solutions provider, Chongqing Haifu Medical Technology Co., Ltd., to introduce innovative high-intensity focused ultrasound tumor therapy system to Hong Kong, positioned to be the first minimally-invasive & non-invasive center in town.

27 Sep 2018

Eisai receives approval for partial label change of DC Bead device for transcatheter arterial embolization

Eisai Co., Ltd. announced that it has received approval for a partial label change for the vascular embolization device DC Bead in Japan.

24 Sep 2018

FDA grants 510(k) clearance to market Gynesonics' Sonata System

Gynesonics, a women's healthcare company focused on the development of minimally invasive solutions for symptomatic uterine fibroids, today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration to market its Sonata Sonography-Guided Transcervical Fibroid Ablation (Sonata) System.

22 Aug 2018

Physical and sexual abuse in childhood associated with endometriosis risk

A large prospective study has found that sexual and physical abuse in childhood and adolescence is associated with a greater risk of endometriosis diagnosed during adulthood.

17 Jul 2018

More studies needed to validate link between air pollution and gynecologic health, say researchers

Hair products used by Black women contain dozens of hazardous chemicals

A new report published today in the journal Environmental Research shows that Black women are potentially exposed to dozens of hazardous chemicals through the hair products they use.

26 Apr 2018

Newly expanded program at Rush offers relief from pelvic floor problems

Trouble with urine or bowel control, bladder pain, recurring urinary tract infections, constipation and other sexual function issues frequently can be traced to a dysfunctional pelvic floor -- the layer of muscles that support the bladder and bowel in men, and bladder, bowel and vagina in women.

6 Apr 2018

UH Cleveland Medical Center explores novel treatments for uterine fibroids

Uterine fibroids, or uterine myomas, can cause symptoms that include unusually long and heavy menstrual flow, pain, enlarged uterus, pressure on the bladder and rectum, and uncomfortable intercourse.

19 Feb 2018

Research highlights decreasing trend in traditional hysterectomy

Fewer women are getting hysterectomies in every state across the country. Instead, more patients may be choosing minimally invasive procedures or other alternatives to handle issues like pelvic pain and fibroids over a traditional abdominal hysterectomy, new Michigan Medicine research suggests.

23 Jan 2018

African-American women with a common form of hair loss linked to greater risk for uterine fibroids

In a study of medical records gathered on hundreds of thousands of African-American women, Johns Hopkins researchers say they have evidence that women with a common form of hair loss have an increased chance of developing uterine leiomyomas, or fibroids.

29 Dec 2017